Altum Sequencing

Altum Sequencing is a biotech firm based in Spain, established in 2019 by physicians and researchers from Madrid's Hospital 12 de Octubre. The company's slogan "Altum Sequencing offers affordable, personalized cancer testing to monitor patients and detect surviving tumor cells" reflects its focus on developing non-invasive solutions for detecting tumor cells that survive cancer treatment. Their goal is to introduce personalized tests allowing medical practitioners to closely monitor and recommend the most appropriate treatment for cancer patients. Altum Sequencing's range of versatile, affordable, and easy-to-use products positions them uniquely in the emerging field of cancer monitoring. With its significant social impact, the company presents an innovative approach to cancer testing and therapy monitoring, making it an intriguing prospect for venture capital investment.